Lunai Bioworks Inc.
LNAI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $42 | $33 | $0 | $0 |
| Gross Profit | -$42 | -$33 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $24 | $80 | -$94 | $161 |
| G&A Expenses | $2,411 | $4,001 | $4,225 | $4,353 |
| SG&A Expenses | $2,411 | $4,001 | $4,225 | $4,353 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $873 | $122,837 | $32 | $32 |
| Operating Expenses | $3,308 | $126,919 | $4,162 | $4,546 |
| Operating Income | -$3,308 | -$126,919 | -$4,162 | -$4,546 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $6,127 | $186 | $4,352 | -$2,706 |
| Pre-Tax Income | $2,819 | -$126,732 | $189 | -$7,252 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $2,819 | -$126,732 | $189 | -$7,252 |
| % Margin | – | – | – | – |
| EPS | 0.13 | -7.61 | 0.012 | -0.4 |
| % Growth | 101.7% | -65,142.7% | 102.9% | – |
| EPS Diluted | 0.13 | -7.61 | 0.012 | -0.4 |
| Weighted Avg Shares Out | 16,660 | 16,660 | 16,233 | 16,183 |
| Weighted Avg Shares Out Dil | 16,660 | 16,660 | 16,393 | 16,183 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $7 | $0 | $0 |
| Interest Expense | $189 | $188 | $189 | $116 |
| Depreciation & Amortization | $42 | $33 | $32 | $32 |
| EBITDA | $2,983 | -$126,512 | $410 | -$7,104 |
| % Margin | – | – | – | – |